
Latin America: cancer biomarkers revenue 2020-2025
By 2025, the forecasted value of the cancer biomarkers market in Latin America is expected to rise to 1.99 billion U.S. dollars, an increase of approximately 70 percent from 1.16 billion U.S. dollars in 2020.